Suraksha Diagnostic Limited has informed the Exchange regarding Resignation of Mr K S Ravindra as Group Chief Financial Officer (CFO), designated as KMP of the company w.e.f. May 31, 2026.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Suraksha Diagnostic Limited has informed the stock exchanges that Mr. K S Ravindra has resigned from the position of Group Chief Financial Officer (CFO), designated as a Key Managerial Personnel (KMP), due to personal reasons. His resignation letter was received on 2 March 2026, and his last working day will be on or before 31 May 2026, serving a 3-month notice period as per his appointment terms. He has confirmed there are no other material reasons for his departure and has committed to cooperating fully for a smooth transition. The company has appreciated his contributions during his tenure as Group CFO.
The departure of the Group CFO is a key management change that investors should monitor closely, as it could create short-term uncertainty around financial leadership. However, the orderly 3-month transition and absence of any flagged material reasons (such as financial irregularities or governance issues) reduce immediate concerns. Shareholders should watch for news of a successor appointment, as continuity in financial reporting and strategy execution will be important.